Earnings Release • May 15, 2017
Earnings Release
Open in ViewerOpens in native device viewer
Bilfinger SE
May 15, 2017
Oil & Gas in North America recovering Especially in shale gas, but also in downstream
Oil & Gas in Northwest-Europe stable on a low level Oil and gas suppliers with significant earnings improvement
Chemicals mixed Development in Europe mixed and market highly competitive, stronger in North America
Conventional energy remains weak
Biopharma with dynamic growth
Orders received still restrained
Reduction in output volume as expected
Adjusted EBITA at prior-year level
Net profit still negative but improved
Operating cash flow improved
Outlook for 2017 confirmed
Quarterly Statement Q1 2017: Business development
• Book-to-bill still <1: Continued selective approach in the project business and demanding market environment
• Output volume: -14% (org.: -15 %) Consequence of decline in orders received in 2016
projects
| Starting Point | Outlook | |
|---|---|---|
| in € million |
FY 2016 | expected FY 2017 |
| Orders received | 4,056 | Organic increase |
| Output volume | 4,219 | Mid-to-high single-digit organic decline |
| Adjusted EBITA / EBITA margin* |
15 / 0.4% | Continued improvement Margin increase ~100bps |
* Assumption: on a comparable F/X basis For further outlook information see: Bilfinger Annual Report 2016, Outlook 2017
Quarterly Statement Q1 2017: Interim financial statement and financial backup
| E&T | MMO | OOP | Consolidation/ other |
Group | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| € million |
Q1 2017 |
Q1 2016 |
Δ in % |
Q1 2017 |
Q1 2016 |
Δ in % |
Q1 2017 |
Q1 2016 |
Δ in % |
Q1 2017 |
Q1 2016 |
Δ in % |
Q1 2017 |
Q1 2016 |
Δ in % |
| Orders received |
242 | 272 | -11% | 603 | 611 | -1% | 88 | 146 | -40% | -5 | -16 | 67% | 928 | 1.013 | -8% |
| Order backlog | 739 | 793 | -7% | 1,637 | 1.683 | -3% | 219 | 411 | -47% | -27 | -38 | 29% | 2,568 | 2,849 | -10% |
| Output volume | 281 | 326 | -14% | 570 | 573 | -1% | 109 | 172 | -37% | -2 | -27 | 93% | 958 | 1.044 | -8% |
| Investments in P,P&E |
2 | 2 | 0% | 9 | 6 | 50% | 2 | 2 | 0% | 2 | 2 | 0% | 15 | 12 | 25% |
| Depreciation P,P&E |
3 | 3 | 0% | 10 | 10 | 0% | 4 | 6 | -33% | 1 | 2 | -50% | 18 | 21 | -14% |
| Amortization | -2 | -2 | 0% | -1 | 0 | n/a | 0 | 0 | 0% | 0 | 0 | 0% | -3 | -2 | -50% |
| EBITA | -9 | -5 | -80% | 12 | 16 | -25% | -5 | -9 | 44% | -48 | -56 | 14% | -50 | -54 | 7% |
| EBITA adjusted | -2 | -5 | 60% | 12 | 18 | -33% | -4 | -5 | 20% | -20 | -23 | 13% | -14 | -15 | 7% |
| EBITA-margin adjusted |
-0.7% | -1.5% | 2.1% | 3.2% | -3.7% | -2.9% | -1.5% | -1.4% |
| € million |
Q1 2017 | Q1 2016 | Δ in % | |
|---|---|---|---|---|
| Output volume | 958 | 1,044 | -8% | -8%, organic -4% |
| Sales revenue | 961 | 1,047 | -8% | |
| Gross profit | 81 | 92 | -12% | |
| Selling and administrative expense | -107 | -124 | 14% | Significant effects in Q1/2017: Expenses from portfolio adjustments (-€14 million / previous year |
| Other operating income and expense | -29 | -25 | -16% | €-22 million Restructuring/severance payments (-€11 million / previous year -€8 million) |
| Income from investments accounted for using the equity method |
2 | 1 | 100% | |
| EBIT | -53 | -56 | 5% | Following depreciation of property, plant and |
| Amortization (IFRS3) | 3 | 2 | 50% | equipment and amortization of intangible assets of €18 million (previous year €21 million) |
| EBITA (for information only) | -50 | -54 | 7% | |
| Special items in EBITA | 36 | 39 | -8% | |
| EBITA adjusted (for information only) | -14 | -15 | 7% |
| € million |
Q1 2017 | Q1 2016 | Δ in % | |
|---|---|---|---|---|
| EBIT | -53 | -56 | 5% | |
| Interest result | -2 | -6 | 67% | Improvement primarily due to interest income Vendor Claim Apleona |
| EBT | -55 | -62 | 11% | |
| Income taxes | 0 | -6 | 100% | |
| Earnings after taxes from continuing operations |
-55 | -68 | 19% | |
| Earnings after taxes from discontinued operations |
0 | -14 | 100% | |
| Earnings after taxes | -55 | -82 | 33% | |
| Minority interest | 0 | 2 | -100% | |
| Net profit | -55 | -80 | 31% | |
| Adjusted net profit | -12 | -13 | 8% | |
| Average number of shares (in thousands) |
44,209 | 44,200 | ||
| Earnings per share (in €) 1 |
-1.24 | -1.81 | 1 Basic earnings per share are equal |
|
| thereof from continuing operations |
-1.24 | -1.49 | to diluted earnings per share. |
|
| thereof from discontinued operations |
0.00 | -0.32 |
| € million | FY 15 | Q1/16 | Q2/16 | Q3/16 | Q4/16 | FY 16 | Q1/17 | In total €~30 million P&L-effect from |
|---|---|---|---|---|---|---|---|---|
| EBITA | -157 | -54 | -64 | -53 | -49 | -221 | -50 | portfolio adjustments (essentially OOP) |
| Disposal losses, write-downs, selling-related expenses |
-48 | 24 | 4 | 35 | 31 | 93 | 13 | This has been already flagged in the valuation net cash as "expected cash-out disposals" in the amount of €30 million at the CMD (Feb. 14) |
| Compliance | 27 | 2 | 6 | 11 | 4 | 23 | 4 | |
| Restructuring and SG&A Efficiency |
155 | 13 | 55 | 27 | 22 | 117 | 17 | FY 2017e: €~90 million |
| IT investments | 0 | 0 | 1 | 2 | 0 | 3 | 2 | |
| Total Adjustments | 134 | 39 | 66 | 75 | 56 | 236 | 36 | |
| EBITA adjusted | -23 | -15 | 2 | 21 | 7 | 15 | -14 | Total Adjustments 2017e: €~120 million |
Non-current assets include non-cash purchase price components Triangle (Vendor Claim €106 million, Preferred Participation Note €195 million)
Decrease in assets classified as held for sale due to deconsolidation OOP
Decrease in equity due to earnings after taxes, Equity Ratio unchanged at 40%
Pension provisions: decrease due to increase interest rate eurozone 1.6 to 1.7%
Financial debt relates to bond of €500 million
Current liabilities contains among others prepayments €100 million (Dec. 31, 2016: €123million)
Decrease in liabilities classified as held for sale due to deconsolidation OOP
| € million |
Mar. 31, 2017 | Dec. 31, 2016 |
|---|---|---|
| Non-current assets | ||
| Intangible assets | 844 | 849 |
| Property, plant and equipment | 380 | 383 |
| Investments accounted for using the equity method | 14 | 10 |
| Other financial assets | 332 | 327 |
| Deferred taxes | 122 | 121 |
| 1,692 | 1,690 |
| Current assets | ||
|---|---|---|
| Inventories | 64 | 57 |
| Receivables and other financial assets | 1,023 | 1,062 |
| Current tax assets | 33 | 27 |
| Other assets | 71 | 70 |
| Cash and cash equivalents | 966 | 1,032 |
| Assets classified as held for sale | 46 | 81 |
| 2,203 | 2,329 | |
| Total | 3,895 | 4,019 |
| € million |
Mar. 31, 2017 |
Dec. 31, 2016 |
|---|---|---|
| Equity | ||
| Equity attributable to shareholders of Bilfinger SE | 1,600 | 1,649 |
| attributable to minority interest | -29 | -28 |
| 1,571 | 1,621 | |
| Non-current liabilities | ||
| Provisions for pensions and similar obligations | 299 | 304 |
| Other provisions | 29 | 28 |
| Financial debt, recourse | 510 | 510 |
| Financial debt, non-recourse | 0 | 0 |
| Other liabilities | 0 | 0 |
| Deferred taxes | 56 | 55 |
| 894 | 897 | |
| Current liabilities | ||
| Current tax liabilities | 38 | 39 |
| Other provisions | 470 | 490 |
| Financial debt, recourse | 10 | 12 |
| Financial debt, non-recourse | 0 | 0 |
| Trade and other payables | 646 | 681 |
| Other liabilities | 210 | 211 |
| Liabilities classified as held for sale | 56 | 68 |
| 1,430 | 1,501 | |
| Total | 3,895 | 4,019 |
| Q1 | ||
|---|---|---|
| € million |
2017 | 2016 |
| Cash earnings from continuing operations | -37 | -32 |
| Change in working capital | -18 | -110 |
| Gains / losses on disposals of non-current assets | 14 | 0 |
| Cash flow from operating activities of continuing operations | -41 | -142 |
| - Thereof special items |
-28 | -54 |
| - Adjusted Cash flow from operating activities of continuing operations |
-13 | -88 |
| Net cash outflow for P, P & E and intangible assets | -14 | -7 |
| Free cash flow from continuing operations | -55 | -149 |
| - Thereof special items |
-28 | -54 |
| - Adjusted Free Cash flow from operating activities of continuing operations |
-27 | -95 |
| Proceeds from the disposal of financial assets | -5 | 190 |
| Investments in financial assets | 0 | -1 |
| Cash flow from financing activities of continuing operations | 0 | -3 |
| - Dividends |
0 | 0 |
| - Repayment of debt |
0 | -3 |
| Change in cash and cash equivalents of continuing operations |
-60 | 37 |
| Change in cash and cash equivalents of discontinued operations |
-9 | -77 |
| Change in value of cash and cash equivalents due to changes in foreign exchange rates | 0 | -1 |
| Change in cash and cash equivalents | -69 | -41 |
| Cash and cash equivalents at January 1 | 1,032 | 475 |
| Change in cash and cash equivalents of assets classified as held for sale |
3 | -1 |
| Cash and cash equivalents at March 31 |
966 | 433 |
| € million |
Mar. 31, 2017 | Dec. 31, 2016 |
|---|---|---|
| Cash and cash equivalents | 966 | 1,032 |
| Financial debt | -520 | -522 |
| Net cash | 446 | 510 |
| Pension provisions | -299 | -304 |
| Expected cash-out disposals | Approx. -30 | Approx. -30 |
| Financial assets (Apleona, JBN) | 320 | 320 |
| Future cash-out special items | Approx. -260 | Approx. -285 |
| Intra-year working capital swing | -50 to -100 |
Approx. -100 |
| Valuation net cash | Approx. 100 | Approx. 100 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.